UNSPSC 51142430: Frovatriptan succinate hydrate

This classification denotes a serotonin agonist with the molecular formula C14H17N3O.C4H6O4.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D28J6W18HY, chemically known as butanedioic acid, compd. with (r)-2,3,4,9-tetrahydro-3-(methylamino)-1h-carbazole-6-carboxamide (1:1), monohydrate, but more generally known as frovatriptan succinate hydrate, which bears US NIH Compound Identifier 152943.

European Medicines Agency schedules frovatriptan succinate hydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07817MIG. Most nations, for tariff purposes, schedule frovatriptan succinate hydrate under HS 29339990. SMILES: CN[C@@H]1CCC2C(C3CC(CCC3[NH]2)C(=O)N)C1.C(CC(=O)O)C(=O)O.O.

UNSPSC 51142430 Frovatriptan succinate hydrate is a Commodity-tier code for a specific migraine pharmaceutical product. Recent state and local procurement activity under this code shows minimal relevant solicitation activity; the three most recent opportunities posted in the source involve naloxone and drug deactivation systems, direct-to-manufacturer pharmacy initiatives, and generic multi-source pharmaceuticals and OTC products — none of which target frovatriptan succinate hydrate specifically. The code appears dormant in state and local procurement channels, with no recent RFP, RFQ, IFB, or ITB solicitations naming frovatriptan succinate hydrate as a line item or primary procurement objective.

Without active recent opportunities under this Commodity code, no geographic concentration, repeat issuing bodies, or representative contract timelines can be identified from current state and local procurement notices. Firms evaluating this code should monitor health and human services agencies, state pharmacy benefit programs, and county health departments for emerging pharmacy modernization initiatives that may generate demand for branded migraine therapeutics, but current activity does not support near-term pursuit.